{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicbwzi24sdepj5goznpywxz6ataelof7uzwzp53vpfqmuh4h4owce",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhiumnqiq5q2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreianws22uifufzo5fteuc3qkbv5oxhoyxlygbagmxfd735uojbukfm"
    },
    "mimeType": "image/jpeg",
    "size": 64416
  },
  "path": "/2026/03/20/chris-klomp-trumprx-high-dose-wegovy-readout-newsletter/?utm_campaign=rss",
  "publishedAt": "2026-03-20T15:32:01.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "STAT+"
  ],
  "textContent": "Today's biotech news includes the Medicare director offering a tempered view of TrumpRx and high-dose Wegovy getting an FDA nod.",
  "title": "STAT+: Medicare chief says TrumpRx is meant to be narrow in scope",
  "updatedAt": "2026-03-20T15:32:05.000Z"
}